| Financial Year |
March 31 2023 |
| Monetary Funds |
269,498,747.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,817,905.66 |
| Accounts Receivable |
321,387,311.28 |
| Advances to Suppliers |
16,872,951.46 |
| Other Receivables |
17,980,077.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
307,026,768.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
538,434,383.41 |
| Other Current Assets |
52,705,623.86 |
| Total Current Assets |
1,539,723,769.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
255,414,969.29 |
| Long-term Equity Investment |
51,381,469.13 |
| Investment Properties |
9,790,231.94 |
| Fixed Assetes |
980,157,816.56 |
| Under-construction Projects |
849,053,051.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,858,777.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
64,769,065.63 |
| Other Non-Current Assets |
281,237,488.79 |
| Sub-Total of Non-Current Assets |
2,689,662,870.11 |
| Total Assets |
4,229,386,639.27 |
| Short-Term Loans |
869,364,297.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,340,321.98 |
| Accounts Payable |
193,089,488.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,985,671.23 |
| Taxes Payable |
4,834,556.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,839,082.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,169,863.60 |
| Other Current Liabilities |
10,385,313.69 |
| Sub-Total of Current Liabilities |
1,251,550,759.71 |
| Long-term Loans |
366,287,544.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
102,121,191.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,790,881.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
506,118,937.69 |
| Total Liabilities |
1,757,669,697.40 |
| Paid-In Capital(Or Share Stock) |
2,199,395,670.00 |
| Capital Surplus |
39,795,664.02 |
| Surplus Reserve |
150,168,068.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
101,571,507.91 |
| Minority Stockholder's Interest |
7,975,357.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,463,741,584.37 |
| Owner's Equity（Stockholder's Equity） |
2,471,716,941.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,229,386,639.27 |
